Category: Treatment

+++ Treatment +++

Blog 3 December WHO Solidarity Trial Consortium. Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results. N Engl J Med 2020, published 2 December. Full-text: https://doi.org/10.1056/NEJMoa2023184 Harrington DP, Baden LR, Hogan JW...

Versatile and multivalent nanobodies

| 6 November | An early inhalation of nanobodies – the future treatment? VHH antibodies or nanobodies (Nbs) are minimal, monomeric antigen-binding domains derived from camelid single-chain antibodies. Unlike IgG antibodies, Nbs are small,...

++ The Textbook ++

| Treatment | 31 October 2020 | Let’s face reality: at the beginning of the second pandemic wave, we have some steroids which have been shown to reduce mortality in patients with severe COVID-19;...

Tocilizumab: No benefit

Tocilizumab was not effective for preventing intubation or death in moderately ill hospitalized patients with Covid-19. This is the result of a randomized, double-blind, placebo-controlled trial involving SARS-CoV-2 patients with hyperinflammatory states and at...

Solidarity Trial: Hydroxychloroquine, Remdesivir etc.

Will remdesivir soon join the hydroxychloroquine and lopinavir graveyard? Interim results from the Solidarity Therapeutics Trial, coordinated by the World Health Organization, indicate that remdesivir, hydroxychloroquine, lopinavir and interferon regimens appear to have little...